Sutro Biopharma (STRO) Return on Invested Capital (2022 - 2025)

Sutro Biopharma has disclosed Return on Invested Capital across 4 years of filings, most recently posting 0.01% for Q4 2025.

• Return on Invested Capital for Q4 2025 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01% (changed N/A YoY), and the FY2025 annual result was 0.04%, changed N/A from the prior year.
• Return on Invested Capital came in at 0.01% for Q4 2025 at Sutro Biopharma, down from 0.03% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.07% in Q2 2025 to a low of 0.01% in Q3 2023.
• The 4-year median for Return on Invested Capital is 0.01% (2023), against an average of 0.0%.
• Across the five-year window, Return on Invested Capital changed 0 bps in 2023 and advanced 7 bps in 2025, its largest moves.
• Sutro Biopharma's Return on Invested Capital stood at 0.01% in 2022, then slumped by 41 bps to 0.01% in 2023, then plunged by 46 bps to 0.01% in 2024, then soared by 227 bps to 0.01% in 2025.
• The last three Return on Invested Capital figures came in at 0.01% (Q4 2025), 0.03% (Q3 2025), and 0.07% (Q2 2025), per Business Quant data.